Bellvitge adopts Roche's automated mass spectrometry, cutting results from a week to a day
Bellvitge Hospital in L'Hospitalet de Llobregat is the first hospital in Catalonia to add fully automated mass spectrometry to its clinical laboratory, developed by Roche Diagnostics. The tool automates everything from sample preparation to result interpretation and shortens result times from a week to a day. It is already used to monitor immunosuppressant drugs in transplant patients and antibiotics in critically ill patients, and the hospital plans to extend it to endocrinology and oncology.
In 40 seconds
- Bellvitge is the first hospital in Catalonia with fully automated mass spectrometry; five other hospitals in Spain already have the tool.
- The process goes from a week to a day and speeds up turnaround times tenfold, according to Roche Diagnostics Spain CEO Adriana Rubio.
- The first care application is monitoring immunosuppressants in transplant patients and antibiotics in critically ill patients.
IASummary generated by artificial intelligence from a story by El Periódico. It may contain errors: the original source prevails.



Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.